FindTrial
Sign In

In This Study Patients With Mild To Moderate Chronic Kidney Disease Secondary To Type II Diabetes Mellitus Will Be Selected To Evaluate The Effect Of Asanadi Niruha Basti

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF ASANADI NIRUHA BASTI IN THE MANAGEMENT OF MILD TO MODERATE CHRONIC KIDNEY DISEASE SECONDARY TO TYPE II DIABETES MELLITUS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106503
Enrollment
30
Registered
2026-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N182- Chronic kidney disease, stage 2 (mild)

Interventions

None listed

Sponsors

Sri Dharmasthala Manjunatheshwara College of Ayurveda Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Estimated Glomerular Filtration Rate (eGFR): (30-100ml/min per 1.73m2) with normal Serum Creatinine: (0.4-1.4 mg/dl) Urine Albumin Creatinine Ratio (uACR): (30-300 mg/g)

Exclusion criteria

Exclusion criteria: CKD subjects of stage-4 and stage-5 are excluded Subjects who are on dialysis therapy Uncontrolled Diabetes Mellitus

Design outcomes

Primary

MeasureTime frame
Samyak niruda lakshana Kidney Disease and Quality of Life (KDQOLTM 36) Estimated Glomerular Filtration Rate (eGFR) with normal Serum Creatinine Urine Albumin Creatinine Ratio (uACR) Timepoint: 0, 9 and 39 days—

Secondary

MeasureTime frame
Generation of data on possible unexpected adverse drug reactions or events Generation of data on quality of life with the test treatment modalities assessed based on Kidney Disease & Quality of Life (KDQOL 36)Timepoint: 0, 9 & 39 days—

Countries

India

Contacts

Public ContactDR PADMAKIRAN C

Sri Dharmasthala Manjunatheshwara College of Ayurveda Hospital and Research Centre

kiranasdm@gmail.com9448953038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026